Open access
864
Views
11
CrossRef citations to date
0
Altmetric
Letter to the Editor
Response to: Monoclonal antibodies targeting CD20
Christian Klein Discovery Oncology; Pharma Research and Early Development (pRED); Roche Glycart AG; Schlieren, SwitzerlandCorrespondence[email protected]
, Alfred Lammens Department of Chemistry and Biochemistry; Gene Center; Ludwig-Maximilians University Munich; Munich, Germany
, Wolfgang Schäfer Large Molecule Research; Pharma Research and Early Development (pRED); Roche Diagnostics GmbH; Penzberg, Germany
, Guy Georges Large Molecule Research; Pharma Research and Early Development (pRED); Roche Diagnostics GmbH; Penzberg, Germany
, Manfred Schwaiger Discovery Oncology; Pharma Research and Early Development (pRED); Roche Diagnostics GmbH; Penzberg, Germany
, Ekkehard Mössner Discovery Oncology; Pharma Research and Early Development (pRED); Roche Glycart AG; Schlieren, Switzerland
, Karl-Peter Hopfner Department of Chemistry and Biochemistry; Gene Center; Ludwig-Maximilians University Munich; Munich, Germany
, Pablo Umaña Discovery Oncology; Pharma Research and Early Development (pRED); Roche Glycart AG; Schlieren, Switzerland
& Gerhard Niederfellner Discovery Oncology; Pharma Research and Early Development (pRED); Roche Diagnostics GmbH; Penzberg, Germany
show all
Pages 337-338
|
Received 12 Feb 2013, Accepted 12 Feb 2013, Published online: 14 Mar 2013
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.